Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes
Clinical trial NCT03406585 · COMPLETED
Trial details
- NCT number
- NCT03406585
- Sponsor
- NextCell Pharma Ab
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2020-07-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.